Dedicated to improving the outcome for heart failure patients with Central Sleep Apnea.
The remedē® System – an innovative implantable stimulation therapy solution.
Central Sleep Apnea and Heart Failure
Heart failure patients have a 1 in 3 chance of having Central Sleep Apnea. Central Sleep Apnea (CSA) is often silent, with symptoms similar to heart failure such as fatigue, poor energy, and nocturia. CSA worsens heart failure progression, decreases quality of life, and increases mortality rates. Treatment of CSA has the potential to improve heart failure symptoms and outcomes.
How the remedē® System Works
The remedē® System is designed to improve central sleep apnea by restoring natural breathing during sleep… one breath at a time™.